Follow
Maya O Nesbit
Maya O Nesbit
Verified email at ubc.ca
Title
Cited by
Cited by
Year
Tetrahydroprotoberberines: a novel source of pharmacotherapies for substance use disorders?
MO Nesbit, AG Phillips
Trends in Pharmacological Sciences 41 (3), 147-161, 2020
182020
Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine
S Ahn, MO Nesbit, H Zou, G Vacca, P Axerio-Cilies, T Van Sung, ...
Scientific Reports 10 (1), 21275, 2020
112020
The effects of d-govadine on conditioned place preference with d-amphetamine or food reward
MO Nesbit, C Dias, AG Phillips
Behavioural Brain Research 321, 223-231, 2017
92017
The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently of D1 receptors
MO Nesbit, A Chai, P Axerio-Cilies, AG Phillips, YT Wang, K Held
Neuropharmacology 207, 108967, 2022
32022
Potentiation of prefrontal cortex dopamine function by the novel cognitive enhancer d-govadine
MO Nesbit, S Ahn, H Zou, SB Floresco, AG Phillips
Neuropharmacology 246, 109849, 2024
2024
Prefrontal cortex mechanisms of the novel cognitive enhancer d-govadine
M Nesbit
University of British Columbia, 2023
2023
D-and l-govadine block d-amphetamine conditioned place preference
M Nesbit, C Dias, A Phillips
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 17, 128-128, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–7